Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study of Jiedu Huayu Oral Prescription in the Treatment of Intracranial Hemorrhage Associated With Cerebral Amyloid Angiopathy
NCT07250035 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study of Jiedu Huayu Oral Prescription in the Treatment of Intracranial Hemorrhage Associated With Cerebral Amyloid Angiopathy
- Lead sponsor
- Beijing Tiantan Hospital
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- January 30, 2026
- Completion date
- November 30, 2028
- Enrollment
- 436 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.